IMMIX BIOPHARMA INC (IMMX:NASDAQ)
$8.69 0.17 (1.9953%)
Analysed IMMIX BIOPHARMA INC (IMMX:NASDAQ) News Sources
We Think Immix Biopharma (NASDAQ:IMMX) Can Afford To Drive Business Growth
05-05-2026
yahoo.com
Is Immix Biopharma (IMMX) One of the Best Performing NASDAQ Stocks?
05-05-2026
yahoo.com
3 Growth Companies With High Insider Ownership Expect Earnings Growth Up To 63%
13-05-2026
yahoo.com
Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2
21-05-2026
yahoo.com
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock
21-05-2026
yahoo.com
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
22-05-2026
yahoo.com
Wall Street Analysts See a 120.59% Upside in Immix Biopharma (IMMX): Can the Stock Really Move This High?
27-05-2026
yahoo.com
Exploring 3 High Growth Tech Stocks in the US Market
09-06-2026
yahoo.com
Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet
18-06-2026
yahoo.com
Straight Out Of A Soap Opera: Biotech Exec Arrested After 21 Years On The Run
21-07-2026
yahoo.com
What is the current price of IMMIX BIOPHARMA INC (IMMX:NASDAQ)?
The current price of IMMIX BIOPHARMA INC (IMMX:NASDAQ) is $8.69.
IMMIX BIOPHARMA INC (IMMX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMIX BIOPHARMA INC (IMMX:NASDAQ) since the previous trading day is $0.17.
IMMIX BIOPHARMA INC (IMMX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMIX BIOPHARMA INC (IMMX:NASDAQ) since the previous trading day is 1.9953%.
What is the most recent average sentiment score for IMMIX BIOPHARMA INC (IMMX:NASDAQ)?
The most recent average sentiment score for IMMIX BIOPHARMA INC (IMMX:NASDAQ) is 50 out of 100.
What is the most recent average sentiment for IMMIX BIOPHARMA INC (IMMX:NASDAQ)?
The most recent sentiment for IMMIX BIOPHARMA INC (IMMX:NASDAQ) is .
SEC-8K** Filing Available For IMMIX BIOPHARMA INC (IMMX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.